In response to final Senate passage of the Drug Quality and Security Act—legislation that establishes a national standard for tracing pharmaceuticals through the drug supply system and clarifies federal authority over pharmaceutical compounding—Allan Coukell, senior director of drugs and medical devices at The Pew Charitable Trusts, issued the following statement.More info
Senior Director, Drugs and Medical Devices , The Pew Charitable Trusts
To reach this expert, please contact:Elizabeth Butler
Allan Coukell is the senior director of drugs and medical devices, including the prescription project, the drug safety project, the antibiotics and innovation project, the medical device initiative and the FDA modernization initiative, as well as other activities related to medical products and services.
He leads the drug safety project's advocacy around the need for reforms to address the risks of the global pharmaceutical manufacturing and distribution supply chain. He has also contributed to the development of federal and state legislation to foster transparency of physician-industry relationships and in the creation of programs to encourage evidence-based prescribing. He has worked closely with medical schools and medical centers developing new industry relations policies, and was co-creator of the American Medical Student Association PharmFree Scorecard, a national assessment of such policies at U.S. medical schools.
Coukell practiced as a clinical pharmacist in oncology at the Victoria Hospital and London Regional Cancer Center in London, Ontario and was subsequently a senior medical writer and editor with Adis International, publisher of the peer-reviewed journals Drugs, Drugs & Aging, and PharmacoEconomics, among others.
He also spent a decade in journalism, ultimately as health and science reporter for WBUR, Boston’s NPR news station. He was the founding producer and host of the weekly Eureka! science program on Radio New Zealand, and has written for The Economist, the New York Times, New Scientist and Discover, among other publications. He is the recipient of an Edward R Murrow award for hard news reporting.
Allan Coukell serves as the consumer representative on the FDA Cardiovascular and Renal Drugs Advisory Committee.
A year after a meningitis outbreak from contaminated pain injections killed at least 64 people and sickened hundreds, Congress is ready to increase federal oversight over compounding pharmacies that custom-mix medications.More info
A year after a deadly fungal meningitis outbreak tied to tainted pain shots, victims like Margaret Snopkowski say they remain devastated by the ordeal — but determined to rebuild their lives.More info
Pew and the Infectious Diseases Society of America applaud Senators Michael Bennet (D-CO) and Orrin Hatch (R-UT) for their leadership in supporting the creation of the Limited Population Antibacterial Drug (LPAD) pathway. Once put in place, LPAD would expedite patient access to critically-needed antibiotics to treat serious or life-threatening infections for which there are currently inadequate treatment options.More info
Pew and the Infectious Diseases Society of America applaud U.S. Representatives Phil Gingrey (R-GA) and Gene Green (D-TX) for their leadership in supporting the creation of the Limited Population Antibacterial Drug (LPAD) pathway. Once put in place, LPAD would expedite patient access to critically-needed antibiotics to treat serious or life-threatening infections for which there are currently inadequate treatment options.More info
Allan Coukell, senior director of drugs and medical devices, sent a letter to Senators Tom Harkin and Lamar Alexander in support of S.959, The Pharmaceutical Quality, Security and Accountability Act. If passed, the bipartisan legislation would improve patient safety by enhancing the security of the drug supply chain.More info
Show All Resources